Teaching clinicians about drugs - 50 years later, whose job is it?

New England Journal of Medicine

Volumn 364, Issue 13, 2011, Pages 1185-1187

  Avorn, Jerry ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

CLINICAL EDUCATION; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; DRUG LEGISLATION; DRUG USE; GENERAL PRACTITIONER; GOVERNMENT; INFORMATION DISSEMINATION; MEDICAL PRACTICE; MEDICAL SOCIETY; PHYSICIAN; POLITICS; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY;

EID: 79953171133     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1011713     Document Type: Short Survey

References (5)

1. Ethical drugs - who shall educate the physician? N Engl J Med 1961;265:910-2.
2. Greene JA, Podolsky SH. Keeping modern in medicine: pharmaceutical promotion and physician education in postwar America. Bull Hist Med 2009;83:331-77.
3. Carpenter D. Reputation and power: organizational image and pharmaceutical regulation at the FDA. Princeton, NJ: Princeton University Press, 2010.
4. Gray BH, Gusmano MK, Collins SR. AHCPR and the changing politics of health services research. Health Aff (Millwood) 2003;Suppl Web Exclusives:W3-283-W3-307.
5. Avorn J. Devising an antidote. In: Avorn J. Powerful medicines: the benefits, risks, and costs of prescription drugs. New York: Alfred A. Knopf, 2005:313-38.